FDA Drug Safety Communication: Possible increased risk of fractures of the hip, wrist, and spine with the use of proton pump inhibitors

Links shared publicly online about this topic.

  • 1,142
    total visits

FDA Drug Safety Communication: Possible increased risk of fractures of the hip, wrist, and spine with the use of proton pump inhibitors

fda.gov —

FDA Drug Safety Communication: Possible increased risk of fractures of the hip, wrist, and spine with the use of proton pump inhibitors

View full resource at fda.gov

Tags: Emergency, Fracture, Drug, FDA

  • Share

Most Recently Shared on May 26, 2010 at 8:04 pm By:

HuntingtonNews Huntington Hospital

#FDA: Possible increased risk of bone fractures and breaks with the use of proton pump inhibitors http://bit.ly/b7yMxG #PPI

2 years ago...

Reply

Retweet

Favorite

Also Shared By:

RitaRubin RitaRubin

Advertisement